Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Journal of Biomedical Science|September 12, 2022
A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodiesMonika Kumari, Ruei-Min Lu, Mu-Chun Li, et al.Plos One|September 9, 2021
Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamstersRakesh Kulkarni, Wen-Ching Chen, Ying Lee, et al.Scientific Reports|April 23, 2021
CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challengeChia-En Lien, Yi-Jiun Lin, Charles Chen, et al.Ebiomedicine|November 28, 2021
Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitroHsiang-Chi Huang, Yun-Ju Lai, Chun-Che Liao, et al.Emerging Microbes & Infections|November 17, 2022
A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concernI-Jung Lee, Yu-Hua Lan, Ping-Yi Wu, et al.Gut|October 2, 2015
Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigenTian-Ying Zhang, Quan Yuan, Jing-Hua Zhao, et al.Journal of Medical Virology|January 7, 2023
Upregulation of PD-L1 by SARS-CoV-2 promotes immune evasionHsiang-Chi Huang, Shih-Han Wang, Guo-Chen Fang, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2023
Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variantsCheng-Pu Sun, Chi-Wen Chiu, Ping-Yi Wu, et al.Plos Pathogens|October 21, 2021
Structure-guided antibody cocktail for prevention and treatment of COVID-19Shih-Chieh Su, Tzu-Jing Yang, Pei-Yu Yu, et al.Plos Pathogens|August 11, 2021
Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19Cheng-Pu Sun, Jia-Tsrong Jan, I-Hsuan Wang, et al.Pageof 4